title: RETRACTED: Evaluation of behavioral problems after prenatal dexamethasone treatment in Swedish adolescents at risk of CAH.
abstract: This article has been retracted: please see Elsevier Policy on Article Withdrawal (http://www.elsevier.com/locate/withdrawalpolicy).
  This article has been retracted at the request of the authors due to technical errors that have called into question the reliability of the data used to inform the author's conclusions.
  All data on cognitive and behavioral outcomes in CAH and non–CAH cases, treated or not treated with DEX prenatally, were put into a single Excel database. The authors had in total four different patient groups for each age group (5–6 y, 7–17 y and 18-35 y). The database consisted of 237 cases in total and there were multiple columns for the different outcome measures.
  When the behavioral data for the sub-cohort described in this paper (first trimester treated non-CAH cases and healthy population controls, age 7–17 y) were copied to another sheet and compressed/modified in preparation for statistical analysis in SPSS, an error occurred. This technological issue caused rows to shift and the data from the different groups got mixed up. In particular, the non–CAH group versus the control group were "contaminated" with cases from the wrong patient group.
  The authors discovered this mistake when they started to analyse the data from the other sub–groups of patients, the CAH cases and the adult cohort, which was after their original results had already been published in Hormones and Behavior in this manuscript "Evaluation of behavioral problems after prenatal dexamethasone treatment in Swedish adolescents at risk of CAH".
  It then became apparent that the entire data set was unreliable and needed to be re–analysed which is what has motivated the retraction of this article. The authors have recently completed this re–analysis and the results have been published here: https://www.sciencedirect.com/science/article/pii/S0018506X17300752
authors.affiliation: Department of Women's and Children's Health, Karolinska Institutet, Pediatric Endocrinology Unit (Q2:08), Karolinska University Hospital, SE-171 76 Stockholm, Sweden.
authors.forename: Lena
authors.initials: L
authors.lastname: Wallensteen
authors.affiliation: Department of Women's and Children's Health, Karolinska Institutet, Pediatric Endocrinology Unit (Q2:08), Karolinska University Hospital, SE-171 76 Stockholm, Sweden.
authors.forename: Marius
authors.initials: M
authors.lastname: Zimmermann
authors.affiliation: Department of Women's and Children's Health, Karolinska Institutet, Pediatric Endocrinology Unit (Q2:08), Karolinska University Hospital, SE-171 76 Stockholm, Sweden.
authors.forename: Malin Thomsen
authors.initials: MT
authors.lastname: Sandberg
authors.affiliation: Department of Women's and Children's Health, Karolinska Institutet, Pediatric Endocrinology Unit (Q2:08), Karolinska University Hospital, SE-171 76 Stockholm, Sweden.
authors.forename: Anton
authors.initials: A
authors.lastname: Gezelius
authors.affiliation: Department of Women's and Children's Health, Karolinska Institutet, Pediatric Endocrinology Unit (Q2:08), Karolinska University Hospital, SE-171 76 Stockholm, Sweden.
authors.forename: Anna
authors.initials: A
authors.lastname: Nordenström
authors.affiliation: Department of Women's and Children's Health, KIND, Karolinska Institutet, Karolinska University Hospital, SE-171 76 Stockholm, Sweden.
authors.forename: Tatja
authors.initials: T
authors.lastname: Hirvikoski
authors.affiliation: Department of Women's and Children's Health, Karolinska Institutet, Pediatric Endocrinology Unit (Q2:08), Karolinska University Hospital, SE-171 76 Stockholm, Sweden. Electronic address: Svetlana.Lajic@ki.se.
authors.forename: Svetlana
authors.initials: S
authors.lastname: Lajic
mesh_terms: D000293:Adolescent; D000294:Adolescent Behavior / Q000187:drug effects*; D000312:Adrenal Hyperplasia, Congenital / Q000453:epidemiology / Q000517:prevention & control*; D000342:Affective Symptoms / Q000139:chemically induced / Q000453:epidemiology; D001007:Anxiety / Q000139:chemically induced / Q000453:epidemiology; D016022:Case-Control Studies; D002648:Child; D003907:Dexamethasone / Q000627:therapeutic use*; D005260:Female; D005938:Glucocorticoids / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D011247:Pregnancy; D011297:Prenatal Exposure Delayed Effects / Q000139:chemically induced / Q000453:epidemiology / Q000523:psychology*; D000066553:Problem Behavior; D012307:Risk Factors; D011795:Surveys and Questionnaires; D013548:Sweden / Q000453:epidemiology; D013694:Temperament / Q000187:drug effects; D014770:Virilism / Q000517:prevention & control* / Q000523:psychology
chemical_list: D005938:Glucocorticoids; D003907:Dexamethasone
keywords: Congenital adrenal hyperplasia; Dexamethasone; Prenatal treatment; Social functioning